BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:KH607 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of KH607\, from ClinicalTrials.gov estimates
 .
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07741240-839@assetmemo.bio
DTSTAMP:20261121T004032Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:KH607: Phase 3 readout est. (NCT07741240)
DESCRIPTION:KH607\, phase 3\, Major Depressive Disorder.\nStudy: A Study of
  KH607 as Monotherpy in Adults Participants With Major Depressive Disorder
 \nEstimated primary completion: December 2027. This is a ClinicalTrials.go
 v estimate\, not a confirmed readout date\, and it can move.\nDrug page: h
 ttps://assetmemo.bio/drug/kh607#upcoming-events\nRegistry record: https://
 clinicaltrials.gov/study/NCT07741240
URL:https://assetmemo.bio/drug/kh607#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07741331-839@assetmemo.bio
DTSTAMP:20261121T004032Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:KH607: Phase 3 readout est. (NCT07741331)
DESCRIPTION:KH607\, phase 3\, Major Depressive Disorder.\nStudy: Compare th
 e Efficacy and Safety of KH607 Tablets Versus Vortioxetine Hydrobromide Ta
 blets in Adult Patients With Major Depressive Disorder\nEstimated primary 
 completion: December 2027. This is a ClinicalTrials.gov estimate\, not a c
 onfirmed readout date\, and it can move.\nDrug page: https://assetmemo.bio
 /drug/kh607#upcoming-events\nRegistry record: https://clinicaltrials.gov/s
 tudy/NCT07741331
URL:https://assetmemo.bio/drug/kh607#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
